-+ 0.00%
-+ 0.00%
-+ 0.00%

Harvard Bioscience forms Scientific Advisory Board, names four industry leaders alongside CEO Duke

PUBT·10/06/2026 20:08:51
Harvard Bioscience forms Scientific Advisory Board, names four industry leaders alongside CEO Duke
  • Harvard Bioscience created a five-member Scientific Advisory Board to guide R&D priorities and new product roadmaps.
  • President and CEO John Duke joined the board; he previously led Plastic Molding Technology, following 25 years at Corning.
  • External appointees include STEMCELL Technologies organoid systems director Ryan Conder, Harvard Medical School drug resistance director Aaron Goldman, Ananda Devices CEO Keith Olson.
  • Board also includes venture capitalist Eric Richman, a director at LabConnect and SafeHeal, with prior CEO roles.
  • The advisory board is scheduled to meet quarterly.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harvard Bioscience Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610061605PRIMZONEFULLFEED9840776) on October 06, 2026, and is solely responsible for the information contained therein.